MENU
BIOY
ETF ticker: NASDAQ
PRICE
CHANGE
NET ASSETS

BIOY stock forecast, quote, news & analysis

The investment seeks is to achieve 3 times (300%) the income generated from selling options on the S&P Biotechnology Select Industry Index (the “underlying index”) by selling options on leveraged exchange-traded funds designed to deliver 3 times (300%) the daily performance of the underlying index (the “Underlying Leveraged ETF”)... Show more

Category: #Trading
Interact to see
Advertisement
A.I.Advisor
published price charts
BIOY
Daily Signal:
Gain/Loss:
A.I.Advisor
a Summary for BIOY with price predictions
Oct 19, 2026

BIOY sees MACD Histogram crosses below signal line

BIOY saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on October 08, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 1 instances where the indicator turned negative. In 1 of the 1 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BIOY as a result. In 2 of 4 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 50%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BIOY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +1.44% 3-day Advance, the price is estimated to grow further. Considering data from situations where BIOY advanced for three days, in 23 of 30 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.

BIOY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 15 of 17 cases where BIOY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 88%.

A.I.Advisor
published Highlights

Industry description

The investment seeks is to achieve 3 times (300%) the income generated from selling options on the S&P Biotechnology Select Industry Index (the “underlying index”) by selling options on leveraged exchange-traded funds designed to deliver 3 times (300%) the daily performance of the underlying index (the “Underlying Leveraged ETF”). It is an actively managed exchange-traded fund (“ETF”) that seeks to pay weekly distributions by selling put options on the Underlying Leveraged ETF, which provides exposure to 3 times the daily performance of the underlying index. The fund is non-diversified.
BIOY sees MACD Histogram crosses below signal line